
Biorce is a pioneering medtech company dedicated to revolutionizing drug development through the power of artificial intelligence (AI). We are passionate about accelerating medical advancements and improving patient outcomes. Our team comprises seasoned clinical research professionals, data scientists, and AI experts, working collaboratively to bridge the gap between cutting-edge technology and real-world clinical needs. With an unwavering commitment to revolutionize healthcare, Biorce envisions a world where all patients benefit from accelerated and cost-effective access to treatments. Our flagship product, Jarvis, stands as the pioneer Clinical AI assistant, granting universal access to clinical data at one's fingertips. Biorce is poised to redefine the landscape of healthcare, shaping a future where innovation and accessibility converge for the betterment of humanity. Join us in our mission to make a positive impact on healthcare. Learn more about our solutions and connect with our team on our LinkedIn page!
Location: Spain
Total raised: $5.85M
Investors 1
Date | Name | Website |
27.12.2024 | YZR Ventur... | yzr.vc |
Funding Rounds 1
Date | Series | Amount | Investors |
09.07.2025 | - | $5.85M | Norrsken V... |
Mentions in press and media 8
Date | Title | Description |
10.07.2025 | Healthtech Pioneer Biorce Secures €5M for Global Clinical Trial Acceleration | Biorce, a Barcelona healthtech firm, secured €5M from Norrsken VC. This capital fuels its AI platform, revolutionizing clinical trials. The technology streamlines drug development, cutting delays and costly amendments. It speeds new therapi... |
09.07.2025 | Biorce raises €5M to accelerate drug development with AI | Barcelona-based healthtech startup Biorce received €5 million in investment from Norrsken VC, Europe’s largest impact VC. The funding comes just seven months after Biorce’s €3.5 million first round in November 2024, led by healthtech specia... |
08.07.2025 | Biorce Raises €5M in Funding | Biorce, a Barcelona, Spain-based healthtech startup, raised €5m in funding. Norrsken VC made the investment. The company intends to use the funds to expand the sales team in the U.S., accelerate product development and to grow from seven to... |
08.07.2025 | Biorce raises €5M to accelerate drug development with AI | Barcelona-based healthtech startup Biorce received €5 million in investment from Norrsken VC, Europe’s largest impact VC. The funding comes just seven months after Biorce’s €3.5 million first round in November 2024, led by healthtech specia... |
29.05.2025 | Barcelona's Masia Fund: Igniting the Tech Revolution | Barcelona is on the brink of a tech renaissance. The launch of the Masia angel fund marks a pivotal moment in this vibrant city’s journey to becoming a European tech powerhouse. Founded by Carlos Trenchs and Pepe Borrell, Masia aims to inje... |
26.05.2025 | New angel fund ‘Masia’ aims to cement Barcelona’s tech hub status | A new angel fund, Masia, has launched in Barcelona. Founded by VC Carlos Trenchs and Pepe Borrell, former co-founder of Crowdcube Europe, Masia aims to accelerate the city’s ascent as a premier European tech hub. The fund, which has operate... |
14.11.2024 | Barcelona-based Biorce secures €3.5 million aiming to transform clinical trials through AI | Biorce, a TechBio company focused on transforming clinical trials through artificial intelligence, has announced the completion of a €3.5 million funding round to accelerate the development of Biorce’s flagship AI model, Jarvis, which aims ... |
- | Biorce | “Biorce - Home” |